First Eagle Investment Management, LLC - SUMMIT THERAPEUTICS PLC ownership

SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 21 filers reported holding SUMMIT THERAPEUTICS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
First Eagle Investment Management, LLC ownership history of SUMMIT THERAPEUTICS PLC
ValueSharesWeighting
Q2 2018$478,000
-81.0%
194,9000.0%0.00%
-83.3%
Q1 2018$2,514,000
+16.4%
194,9000.0%0.01%
+20.0%
Q4 2017$2,159,000
-1.4%
194,900
+11.4%
0.01%0.0%
Q3 2017$2,190,000
+13.9%
174,9000.0%0.01%0.0%
Q2 2017$1,922,000
-17.6%
174,9000.0%0.01%
-16.7%
Q1 2017$2,333,000
+55.7%
174,900
-0.1%
0.01%
+50.0%
Q4 2016$1,498,000
-6.8%
175,0000.0%0.00%0.0%
Q3 2016$1,607,000
+16.1%
175,0000.0%0.00%0.0%
Q2 2016$1,384,000
+13.0%
175,0000.0%0.00%
+33.3%
Q1 2016$1,225,000
-39.0%
175,0000.0%0.00%
-40.0%
Q4 2015$2,009,000
+10.3%
175,0000.0%0.01%0.0%
Q3 2015$1,822,000
-6.3%
175,0000.0%0.01%0.0%
Q2 2015$1,944,000
-10.3%
175,0000.0%0.01%0.0%
Q1 2015$2,168,000175,0000.01%
Other shareholders
SUMMIT THERAPEUTICS PLC shareholders Q3 2017
NameSharesValueWeighting ↓
Worth Asset Management, LLC 10,956$20,4880.02%
Lindbrook Capital, LLC 782$1,4620.00%
View complete list of SUMMIT THERAPEUTICS PLC shareholders